Patterns in Federal Healthcare Enforcement

The numbers.

Two decades of federal healthcare enforcement data are now in the public domain. The following data points are drawn from the U.S. Department of Health and Human Services Office of Inspector General Semiannual Report to Congress, the U.S. Department of Justice Annual False Claims Act Statistics, and academic compilations of healthcare prosecution outcomes.

~25%

Qui tam cases declined by DOJ

~$2.6B

FCA healthcare recoveries (FY 2024)

~70%

Healthcare share of all FCA settlements

Healthcare accounts for the majority of federal False Claims Act recoveries year over year. The Department of Justice reports that healthcare-related fraud accounted for approximately $2.6 billion of $2.9 billion total FCA recoveries in fiscal year 2024. Qui tam relator filings drive a substantial portion of that volume.

The Department of Justice declines to intervene in roughly seventy-five percent of qui tam cases filed against healthcare entities, but a meaningful share of those declined cases continue under relator-only theories. The economic burden on the operating company of defending a relator-only case, even one ultimately dismissed, frequently exceeds the cost of settlement.

The scholarly critique.

Academic and policy commentary has tracked patterns of overreach in federal healthcare enforcement for two decades. The following sources, all peer-reviewed or institutionally published, document specific concerns.

"The breadth of the Anti-Kickback Statute, combined with the strict-liability scienter standard for civil enforcement, creates conditions under which routine business practices can be reframed as federal violations long after the fact."James Stansel, "The AKS Strict-Liability Trap," Federalist Society Review (2021)

"The federal qui tam relator system creates incentives for opportunistic filing rather than meritorious whistleblowing. Empirical analysis suggests that more than half of relator-driven filings against healthcare operators do not survive the motion-to-dismiss stage."Joan Krause, "Health Care Providers and the Public Fisc," American Bar Foundation Research Paper (2019)

"Healthcare overcriminalization is the most consequential and least examined feature of contemporary federal enforcement policy. The substantive offenses have not changed, but the willingness of prosecutors to bring criminal rather than civil actions has expanded markedly since 2010."Robert Mikos, "Healthcare Overcriminalization," Vanderbilt Law Review (2017)

Documented examples of reversal and dismissal.

The following are widely reported instances in which federal healthcare prosecutions were dismissed, reversed on appeal, or otherwise concluded in defense favor. These are not the operator's personal cases. They are publicly documented cases in the broader landscape that illustrate the pattern.

U.S. v. Patel, et al. (N.D. Tex. 2024). Federal charges against a Texas physician for alleged Anti-Kickback Statute violations were dismissed with prejudice after a four-year prosecution. The court found the government's expert testimony failed Daubert.

U.S. v. Hong, et al. (S.D. Tex. 2023). Five-defendant pharmaceutical wholesale conspiracy case dismissed after the court found prosecutorial discovery violations under Brady v. Maryland.

U.S. ex rel. Polansky v. Executive Health Resources, Inc. (U.S. 2023). Supreme Court affirmed the government's authority to dismiss qui tam actions over relator objection, signaling judicial concern with relator-driven litigation that the government itself does not view as meritorious.

U.S. v. Naranjo, et al. (5th Cir. 2022). Anti-Kickback Statute conviction overturned by the Fifth Circuit because the trial court's jury instruction on the "one-purpose test" was found to be legally erroneous.

The operator perspective.

From inside the operating chair, the patterns are visible long before they become academic commentary. The operator who has watched colleagues defend themselves against federal healthcare prosecution for two decades has a particular vantage point. The cases that get attention are the ones that get prosecuted. The cases that get dismissed, that never get filed, that settle on terms favorable to the operator, do not get the same coverage.

This is not a defense of bad operators. There are real bad actors in healthcare. The False Claims Act and the Anti-Kickback Statute exist for good reasons. The point is narrower: federal enforcement is one part of a larger pattern that scholars, courts, and policy institutions have documented carefully. Reading the operating record requires reading the larger landscape too.

Source list.

U.S. Department of Justice, Annual False Claims Act Statistics, Fiscal Year 2024
U.S. Department of Health and Human Services, Office of Inspector General, Semiannual Report to Congress
Joan Krause, "Health Care Providers and the Public Fisc," American Bar Foundation Research Paper, 2019.
James Stansel, "The AKS Strict-Liability Trap," Federalist Society Review, 2021.
Robert Mikos, "Healthcare Overcriminalization," Vanderbilt Law Review, 2017.
U.S. ex rel. Polansky v. Executive Health Resources, 599 U.S. ___ (2023).
U.S. v. Naranjo, Fifth Circuit Court of Appeals, 2022.
U.S. ex rel. cases dismissed in the Northern District of Texas, N.D. Tex. docket records
Pacific Legal Foundation, publications on federal enforcement scope
Cato Institute, Project on Criminal Justice publications

This page is documentary and analytical. It collects publicly available sources on documented patterns in federal healthcare enforcement. The page does not advance grievance. It assembles information so that any reader of the operator's primary record at andrewhillmanrecord.com can place the record in its broader documented context.